MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International EBITDA per Share 2011-2026 | MTD
Annual EBITDA per Share Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 | 2.37 | 2.24 | 2.08 | 1.94 | 1.76 | 31.7 | 29 | 25.5 | 22 | 19.2 | 17.5 | 15.8 | 14.3 | 12.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.7 | 1.76 | 13.4 |
Quarterly EBITDA per Share Mettler-Toledo International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.62 | 0.62 | 0.6 | - | 0.61 | 0.58 | 0.58 | - | 0.32 | 0.31 | 0.54 | - | 0.3 | 0.29 | 0.52 | - | 1.45 | 0.27 | 0.47 | - | 1.29 | 0.85 | 0.42 | - | 1.2 | 0.79 | 0.39 | - | 1.11 | 0.74 | 0.36 | - | 0.95 | 0.62 | 0.31 | - | 0.93 | 0.61 | 0.3 | - | 0.91 | 0.6 | 0.3 | - | 0.89 | 0.58 | 0.29 | - | 0.87 | 0.58 | 0.29 | - | 0.79 | 0.52 | 0.25 | - | 0.76 | 0.48 | 0.23 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.45 | 0.23 | 0.606 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.9 | 2.47 % | $ 94.1 K |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 120.64 | 1.34 % | $ 36.7 B | USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 22.35 | -5.06 % | $ 234 M |  China |
 |
Castle Biosciences
CSTL
|
0.89 | $ 28.19 | 2.25 % | $ 783 M | USA |
 |
Celcuity
CELC
|
-2.87 | $ 109.32 | 1.79 % | $ 4.31 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 14.32 | 3.84 % | $ 433 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 179.75 | 2.31 % | $ 8.91 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
IDEXX Laboratories
IDXX
|
18.7 | $ 642.67 | 1.12 % | $ 51.7 B | USA |
 |
Illumina
ILMN
|
-3.01 | $ 130.61 | 0.81 % | $ 20.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 281.85 | -0.43 % | $ 23.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 78.2 | -0.81 % | $ 5.28 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-0.22 | $ 14.8 | -4.55 % | $ 1.92 B | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 5.44 | 2.84 % | $ 504 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.43 | -1.15 % | $ 1.21 B | USA |
 |
BioNano Genomics
BNGO
|
-70.8 | $ 1.14 | 1.79 % | $ 1.45 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 208.79 | 0.21 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 205.33 | 0.65 % | $ 146 B | USA |
 |
National Research Corporation
NRC
|
1.64 | $ 13.41 | 0.15 % | $ 329 M | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | $ 103.39 | 0.02 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
-0.39 | $ 8.68 | -0.69 % | $ 544 M | USA |
 |
OPKO Health
OPK
|
-0.08 | $ 1.21 | 1.26 % | $ 840 M | USA |
 |
DarioHealth Corp.
DRIO
|
-1.96 | $ 10.3 | -0.05 % | $ 292 M | Israel |
 |
DexCom
DXCM
|
2.98 | $ 72.89 | -0.26 % | $ 28.4 B | USA |
 |
PerkinElmer
PKI
|
6.54 | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.61 | 5.92 % | $ 483 M | USA |
 |
Psychemedics Corporation
PMD
|
-0.21 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.35 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 109.33 | 0.58 % | $ 9.02 B |  Irlanda |
 |
Quotient Limited
QTNT
|
-0.806 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Precipio
PRPO
|
-4.93 | $ 25.89 | 3.64 % | $ 33.6 M | USA |
 |
Personalis
PSNL
|
-0.97 | $ 8.94 | 3.11 % | $ 530 M | USA |
 |
Renalytix AI plc
RNLX
|
-0.27 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 19.15 | 1.86 % | $ 1.02 B | USA |